These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 14697864)

  • 1. The use of animal models in developing the discipline of cardiovascular tissue engineering: a review.
    Rashid ST; Salacinski HJ; Hamilton G; Seifalian AM
    Biomaterials; 2004 Apr; 25(9):1627-37. PubMed ID: 14697864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioreactors for cardiovascular cell and tissue growth: a review.
    Barron V; Lyons E; Stenson-Cox C; McHugh PE; Pandit A
    Ann Biomed Eng; 2003 Oct; 31(9):1017-30. PubMed ID: 14582605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of tissue-engineering principles toward the development of a semilunar heart valve substitute.
    Breuer CK; Mettler BA; Anthony T; Sales VL; Schoen FJ; Mayer JE
    Tissue Eng; 2004; 10(11-12):1725-36. PubMed ID: 15684681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cells for tissue engineering of cardiac valves.
    Jana S; Tranquillo RT; Lerman A
    J Tissue Eng Regen Med; 2016 Oct; 10(10):804-824. PubMed ID: 25712485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Status of Tissue Engineering Heart Valve.
    Shinoka T; Miyachi H
    World J Pediatr Congenit Heart Surg; 2016 Nov; 7(6):677-684. PubMed ID: 27834758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
    Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
    Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue engineering of heart valves -- current aspects.
    Stock UA; Vacanti JP; Mayer Jr JE; Wahlers T
    Thorac Cardiovasc Surg; 2002 Jun; 50(3):184-93. PubMed ID: 12077696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioengineered living cardiac and venous valve replacements: current status and future prospects.
    Kehl D; Weber B; Hoerstrup SP
    Cardiovasc Pathol; 2016; 25(4):300-305. PubMed ID: 27167776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrates for cardiovascular tissue engineering.
    Bouten CV; Dankers PY; Driessen-Mol A; Pedron S; Brizard AM; Baaijens FP
    Adv Drug Deliv Rev; 2011 Apr; 63(4-5):221-41. PubMed ID: 21277921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart valve tissue engineering.
    Neuenschwander S; Hoerstrup SP
    Transpl Immunol; 2004 Apr; 12(3-4):359-65. PubMed ID: 15157927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue engineering of heart valves by recellularization of glutaraldehyde-fixed porcine valves using bone marrow-derived cells.
    Kim SS; Lim SH; Cho SW; Gwak SJ; Hong YS; Chang BC; Park MH; Song KW; Choi CY; Kim BS
    Exp Mol Med; 2006 Jun; 38(3):273-83. PubMed ID: 16819286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells.
    Schmidt D; Dijkman PE; Driessen-Mol A; Stenger R; Mariani C; Puolakka A; Rissanen M; Deichmann T; Odermatt B; Weber B; Emmert MY; Zund G; Baaijens FP; Hoerstrup SP
    J Am Coll Cardiol; 2010 Aug; 56(6):510-20. PubMed ID: 20670763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart valve tissue engineering: how far is the bedside from the bench?
    Sanz-Garcia A; Oliver-de-la-Cruz J; Mirabet V; Gandía C; Villagrasa A; Sodupe E; Escobedo-Lucea C
    Expert Rev Mol Med; 2015 Sep; 17():e16. PubMed ID: 26399177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioengineering challenges for heart valve tissue engineering.
    Sacks MS; Schoen FJ; Mayer JE
    Annu Rev Biomed Eng; 2009; 11():289-313. PubMed ID: 19413511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing a Clinically Relevant Tissue Engineered Heart Valve-A Review of Current Approaches.
    Nachlas ALY; Li S; Davis ME
    Adv Healthc Mater; 2017 Dec; 6(24):. PubMed ID: 29171921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter tissue engineered heart valves.
    Emmert MY; Weber B; Falk V; Hoerstrup SP
    Expert Rev Med Devices; 2014 Jan; 11(1):15-21. PubMed ID: 24308737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical Animal Models for Temporomandibular Joint Tissue Engineering.
    Almarza AJ; Brown BN; Arzi B; Ângelo DF; Chung W; Badylak SF; Detamore M
    Tissue Eng Part B Rev; 2018 Jun; 24(3):171-178. PubMed ID: 29121815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three myofibroblast cell sources for the tissue engineering of cardiac valves.
    Hoffman-Kim D; Maish MS; Krueger PM; Lukoff H; Bert A; Hong T; Hopkins RA
    Tissue Eng; 2005; 11(1-2):288-301. PubMed ID: 15738682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth.
    Weber B; Zeisberger SM; Hoerstrup SP
    Placenta; 2011 Oct; 32 Suppl 4():S316-9. PubMed ID: 21575988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human or animal homograft: could they have a future as a biological scaffold for engineered heart valves?
    Dainese L; Biglioli P
    J Cardiovasc Surg (Torino); 2010 Jun; 51(3):449-56. PubMed ID: 20523298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.